Clinical trial
Identification of a Plasma Proteomic Signature for Lung Cancer
NCT01752101 · Integrated Diagnostics, Industry · Completed
Key facts
| NCT number | NCT01752101 |
|---|---|
| Title | Identification of a Plasma Proteomic Signature for Lung Cancer |
| Official title | Identification of a Plasma Proteomic Signature for Lung Cancer |
| Lead sponsor | Integrated Diagnostics, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Precancerous Conditions, Carcinoma |
| Enrollment | 475 |
| Start date | Oct 1, 2012 |
| Primary completion | Dec 1, 2014 |
| Completion | Dec 1, 2014 |
| First posted | Dec 19, 2012 |
| Last update posted | Jan 9, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: